Adaptive Biotechnologies ADPT Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $77.58M+53.2% | $70.5M+47.1% | $55.03M+44.5% | $43.16M-27.9% | $50.65M-28.9% | ||
| $140.75M-1.4% | $156.49M-10.3% | $157.74M-23.1% | $154.71M-33.3% | $142.78M-39.9% | ||
| $2.71M-0.1% | $2.69M-7.2% | $2.69M-9.7% | $2.72M-8.6% | $2.71M-8.5% | ||
| $48.32M+10.9% | $50.37M+20.7% | $44.82M+9.8% | $44.29M+24.4% | $43.58M+3.7% | ||
| $11.21M+29.0% | $9.82M+16.4% | $9.93M-16.9% | $8.4M-36.4% | $8.68M-34.7% | ||
| $13.95M+29.2% | $13.02M+15.4% | $13.91M+13.6% | $11.3M+4.1% | $10.8M+9.6% | ||
| $291.81M+13.8% | $300.19M+5.8% | $281.44M-8.7% | $261.86M-25.5% | $256.49M-31.4% | ||
| $30.77M-30.7% | $34.11M-29.8% | $37.5M-26.9% | $41.06M-25.9% | $44.43M-31.9% | ||
| $40.25M-8.5% | $40.62M-11.3% | $41.99M-9.8% | $43.34M-10.7% | $44M-13.7% | ||
| $118.97M0.0% | $118.97M0.0% | $118.97M0.0% | $118.97M0.0% | $118.97M0.0% | ||
| $1.31M-56.5% | $1.73M-49.6% | $2.16M-44.1% | $2.58M-39.7% | $3.01M-36.1% | ||
| $1.24M-34.4% | $1.21M-47.2% | $1.84M-30.7% | $2.01M-36.1% | $1.89M-44.4% | ||
| $18.89M-52.0% | $13.23M-60.7% | $4.04M-83.1% | $24.1M— | $39.36M— | ||
| $505.94M-1.0% | $512.74M-4.9% | $490.61M-12.2% | $496.64M-15.1% | $510.85M-17.6% | ||
| $9.62M+51.1% | $6.47M-11.0% | $10.27M+39.7% | $6.91M-30.0% | $6.36M-47.7% | ||
| $6.22M-3.0% | $16.99M+7.3% | $12.68M+2.8% | $9.7M+1.9% | $6.41M+0.1% | ||
| $49.4M-9.9% | $45.19M-18.8% | $41.34M-20.3% | $55.3M+5.9% | $54.81M+16.9% | ||
| $5.8M+189% | $4.64M+437% | $2.43M— | $3.07M— | $2.01M— | ||
| $8.51M-18.6% | $8.92M-12.9% | $9.44M-5.8% | $9.96M+1.5% | $10.46M+9.0% | ||
| $807K-96.7% | $1.01M-96.3% | $1.21M-96.3% | $20.03M-48.4% | $24.81M-43.8% | ||
| $87.01M-0.9% | $89.92M-8.3% | $83.36M-4.9% | $92.14M+4.6% | $87.81M+5.9% | ||
| $124.75M-5.2% | $126.57M-4.4% | $129.41M-2.5% | $130.5M-1.2% | $131.55M0.0% | ||
| $69.12M-9.6% | $70.23M-11.3% | $72.36M-11.5% | $74.41M-11.8% | $76.44M-12.0% | ||
| $77.63M-10.7% | $79.15M-11.5% | $81.8M-10.9% | $84.37M-10.4% | $86.9M-9.9% | ||
| $20K0.0% | $20K0.0% | $20K0.0% | $20K0.0% | $20K— | ||
| $281.7M-12.1% | $287.74M-14.6% | $286.36M-14.5% | $317.1M-7.7% | $320.63M-7.2% | ||
| $16K+6.7% | $15K+7.1% | $15K+7.1% | $15K+7.1% | $15K+7.1% | ||
| $1.6B+5.0% | $1.58B+5.0% | $1.55B+4.1% | $1.54B+4.0% | $1.52B+3.9% | ||
| -$1.38B-3.7% | -$1.36B-4.6% | -$1.35B-6.3% | -$1.36B-9.8% | -$1.33B-11.9% | ||
| -$28K-121% | $253K+52.4% | $211K-57.5% | $73K+140% | $134K+226% | ||
| $7.9M+4,011% | $6.21M+2,871% | -$182K+8.5% | -$181K-4.6% | -$202K-37.4% | ||
| $216.34M+13.6% | $218.79M+7.9% | $204.44M-8.6% | $179.72M-25.6% | $190.42M-30.7% | ||
| $505.94M-1.0% | $512.74M-4.9% | $490.61M-12.2% | $496.64M-15.1% | $510.85M-17.6% | ||
| $140.75M-1.4% | $156.49M-10.3% | $157.74M-23.1% | $154.71M-33.3% | $142.78M-39.9% | ||
| $1.24M-34.4% | $1.21M-47.2% | $1.84M-30.7% | $2.01M-36.1% | $1.89M-44.4% | ||
| $40.25M-8.5% | $40.62M-11.3% | $41.99M-9.8% | $43.34M-10.7% | $44M-13.7% | ||
| $18.89M-52.0% | $13.23M-60.7% | $4.04M-83.1% | $24.1M— | $39.36M— | ||
| $1.31M-56.5% | $1.73M-49.6% | $2.16M-44.1% | $2.58M-39.7% | $3.01M-36.1% | ||
| $40.25M-8.5% | $40.62M-11.3% | $41.99M-9.8% | $43.34M-10.7% | $44M-13.7% | ||
| $1.24M-34.4% | $1.21M-47.2% | $1.84M-30.7% | $2.01M-36.1% | $1.89M-44.4% | ||
| $40.25M-8.5% | $40.62M-11.3% | $41.99M-9.8% | $43.34M-10.7% | $44M-13.7% | ||
| $1.24M-34.4% | $1.21M-47.2% | $1.84M-30.7% | $2.01M-36.1% | $1.89M-44.4% | ||
| $6.22M-3.0% | $16.99M+7.3% | $12.68M+2.8% | $9.7M+1.9% | $6.41M+0.1% | ||
| $807K-96.7% | $1.01M-96.3% | $1.21M-96.3% | $20.03M-48.4% | $24.81M-43.8% | ||
| $7.47M-3.8% | $7.7M-5.6% | $7.21M+18.9% | $7.21M+7.4% | $7.76M-2.0% | ||
| $7.47M-3.8% | $7.7M-5.6% | $7.21M+18.9% | $7.21M+7.4% | $7.76M-2.0% | ||
| $6.22M-3.0% | $16.99M+7.3% | $12.68M+2.8% | $9.7M+1.9% | $6.41M+0.1% | ||
| $807K-96.7% | $1.01M-96.3% | $1.21M-96.3% | $20.03M-48.4% | $24.81M-43.8% | ||
| $807K-96.7% | $1.01M-96.3% | $1.21M-96.3% | $20.03M-48.4% | $24.81M-43.8% | ||
| $208.18M-5.6% | $210.36M-5.5% | $213.64M-4.8% | $217.94M-3.7% | $220.46M-3.3% | ||
| $16K+6.7% | $15K+7.1% | $15K+7.1% | $15K+7.1% | $15K+7.1% | ||
| $7.9M+4,011% | $6.21M+2,871% | -$182K+8.5% | -$181K-4.6% | -$202K-37.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Adaptive Biotechnologies's total assets?
- Adaptive Biotechnologies (ADPT) holds $505.9M in total assets, down 1.0% year over year.
- How much debt does Adaptive Biotechnologies have?
- Adaptive Biotechnologies carries $208.2M in total debt against $216.3M of shareholders' equity, a debt-to-equity ratio of 0.96.
- How much cash does Adaptive Biotechnologies have?
- Adaptive Biotechnologies holds $77.6M in cash and equivalents.
- Can Adaptive Biotechnologies cover its short-term obligations?
- Its current ratio is 3.35 — current assets exceed current liabilities.
- Where does Adaptive Biotechnologies's balance sheet data come from?
- Every line is extracted from Adaptive Biotechnologies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
